Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation

NCT ID: NCT06611800

Last Updated: 2024-10-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

256 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-01

Study Completion Date

2024-10-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective data collection on the files of patients cared for by the mobile palliative care team of the William Morey Hospital Center who died in 2022.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Retrospective selection of patients and collection of data : pathology, identified risk, presence of caregiver, end-of-life wishes, characteristics of palliative care treatment, circumstances of death. Comparison of two groups : presence or absence of personalized advance prescriptions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palliative Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Presence or absence of personalized advance prescriptions

collection of data for the purpose of know the benefit of personalized advance prescriptions for patients in palliative care at home, particularly in reducing the number of visits to the emergency room and their conditions of death

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minimum 18 years old
* Taken care of once in their place of life by a palliative care team
* Died between 01/01/2022 and 12/31/2022 in William Morey Hospital Center
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier William Morey - Chalon sur Saône

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Julie COLLOT

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julie COLLOT

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier William Morey

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH William Morey

Chalon-sur-Saône, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.

Reference Type RESULT
PMID: 20818875 (View on PubMed)

Haun MW, Estel S, Rucker G, Friederich HC, Villalobos M, Thomas M, Hartmann M. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD011129. doi: 10.1002/14651858.CD011129.pub2.

Reference Type RESULT
PMID: 28603881 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAPHOME

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.